Back to Search Start Over

Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.

Authors :
Recanatini, C.
GeurtsvanKessel, C.H.
Pas, S.D.
Broens, E.M.
Maas, M
Mansfeld, R. van
Mutsaers-van Oudheusden, A.J.G.
Rijen, M. van
Schippers, E.F.
Stegeman, A.
Tami, A.
Veldkamp, K.E.
Visser, H.
Voss, A.
Wegdam-Blans, M.C.
Wertheim, H.F.L.
Wever, P.C.
Koopmans, M.P.
Kluytmans, Jan
Kluytmans-van den Bergh, M.F.Q.
Recanatini, C.
GeurtsvanKessel, C.H.
Pas, S.D.
Broens, E.M.
Maas, M
Mansfeld, R. van
Mutsaers-van Oudheusden, A.J.G.
Rijen, M. van
Schippers, E.F.
Stegeman, A.
Tami, A.
Veldkamp, K.E.
Visser, H.
Voss, A.
Wegdam-Blans, M.C.
Wertheim, H.F.L.
Wever, P.C.
Koopmans, M.P.
Kluytmans, Jan
Kluytmans-van den Bergh, M.F.Q.
Source :
Antimicrobial Resistance and Infection Control, 12, 1, pp. 137
Publication Year :
2023

Abstract

Item does not contain fulltext<br />BACKGROUND: We aimed to estimate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and describe its determinants and associated symptoms among unvaccinated healthcare workers (HCWs) after the first wave of the pandemic. METHODS: HCWs from 13 Dutch hospitals were screened for antibodies against the spike protein of SARS-CoV-2 in June-July 2020 and after three months. Participants completed a retrospective questionnaire on determinants for occupational and community exposure to SARS-CoV-2 and symptoms suggestive of COVID-19 experienced since January 2020. The seroprevalence was calculated per baseline characteristic and symptom at baseline and after follow-up. Adjusted odds ratios (aOR) for seropositivity were determined using logistic regression. RESULTS: Among 2328 HCWs, 323 (13.9%) were seropositive at enrolment, 49 of whom (15%) reported no previous symptoms suggestive of COVID-19. During follow-up, only 1% of the tested participants seroconverted. Seroprevalence was higher in younger HCWs compared to the mid-age category (aOR 1.53, 95% CI 1.07-2.18). Nurses (aOR 2.21, 95% CI 1.34-3.64) and administrative staff (aOR 1.87, 95% CI 1.02-3.43) had a higher seroprevalence than physicians. The highest seroprevalence was observed in HCWs in the emergency department (ED) (aOR 1.79, 95% CI 1.10-2.91), the lowest in HCWs in the intensive, high, or medium care units (aOR 0.47, 95% CI 0.31-0.71). Chronic respiratory disease, smoking, and having a dog were independently associated with a lower seroprevalence, while HCWs with diabetes mellitus had a higher seroprevalence. In a multivariable model containing all self-reported symptoms since January 2020, altered smell and taste, fever, general malaise/fatigue, and muscle aches were positively associated with developing antibodies, while sore throat and chills were negatively associated. CONCLUSIONS: The SARS-CoV-2 seroprevalence in unvaccinated HCWs of 13 Dutch hospitals was 14% in June-July 2020 an

Details

Database :
OAIster
Journal :
Antimicrobial Resistance and Infection Control, 12, 1, pp. 137
Publication Type :
Electronic Resource
Accession number :
edsoai.on1414568187
Document Type :
Electronic Resource